Manlio Fusciello

Helsinki, 00014, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Corrigendum to 'Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio 36, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693].

Corrigendum to 'Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio 36, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693].

Journal: Materials today. Bio
Published: April 02, 2026

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Journal: Molecular therapy. Oncology
Published: October 29, 2025

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: October 10, 2025

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Journal: Nature communications
Published: April 16, 2025

What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication.

What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication.

Journal: Molecular therapy. Oncology
Published: March 31, 2025

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Journal: Oncoimmunology
Published: October 01, 2024

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches.

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches.

Journal: Bioactive materials
Published: September 18, 2024

An automated and high-throughput approach for enhanced precision of adenoviral titering.

An automated and high-throughput approach for enhanced precision of adenoviral titering.

Journal: Molecular therapy. Methods & clinical development
Published: August 08, 2024

Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.

Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.

Journal: Oncoimmunology
Published: June 25, 2024

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Journal: Journal for immunotherapy of cancer
Published: February 18, 2024

Personalizing Oncolytic Virotherapy.

Personalizing Oncolytic Virotherapy.

Journal: Human gene therapy
Published: September 12, 2023

PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.

PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.

Journal: International journal of biological macromolecules
Published: August 01, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026